Luke Anson
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 5%
- Enterobacteriaceae and Cronobacter Research
Papers in
-
- Antimicrobial Resistance in Staphylococcus 2
- Clostridium difficile and Clostridium perfringens research 1
-
- Bacterial Identification and Susceptibility Testing 4
- Co-authors
- Derrick W. Crook (8 shared papers)Tim Peto (6 shared papers)Louise Pankhurst (4 shared papers)A. Sarah Walker (3 shared papers)Anna E. Sheppard (4 shared papers)Robert Sebra (4 shared papers)Andrew Kasarskis (4 shared papers)Nicole Stoesser (4 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Health Technology Assessment (1 paper)Journal of Clinical Microbiology (1 paper)Journal of Medical Microbiology (1 paper)Journal of Hospital Infection (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Luke Anson
8 papers receiving 394 citations
Peers
Comparison fields: 5 of 43
- Molecular Medicine 211
- Endocrinology 99
- Clinical Biochemistry 69
- Applied Microbiology and Biotechnology 16
- Infectious Diseases 132
Countries citing papers authored by Luke Anson
This map shows the geographic impact of Luke Anson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Anson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Anson more than expected).
Fields of papers citing papers by Luke Anson
This network shows the impact of papers produced by Luke Anson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Anson. The network helps show where Luke Anson may publish in the future.
Co-authors
The 25 scholars most cited alongside Luke Anson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 216 | |
| 2 | 2015 | 74 | |
| 3 | 2018 | 23 | |
| 4 | 2017 | 23 | |
| 5 | 2016 | 18 | |
| 6 | 2014 | 16 | |
| 7 | 2016 | 13 | |
| 8 | 2016 | 13 |
About Luke Anson
Luke Anson is a scholar working on Infectious Diseases, Clinical Biochemistry, Molecular Medicine, Epidemiology and Endocrinology, having authored 8 papers that have together received 396 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (4 papers), Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Mycobacterium research and diagnosis (2 papers), Genomics and Phylogenetic Studies (1 paper), Salmonella and Campylobacter epidemiology (1 paper), Clostridium difficile and Clostridium perfringens research (1 paper) and Infective Endocarditis Diagnosis and Management (1 paper). The work is most often cited by research in Molecular Medicine (211 citations), Endocrinology (99 citations), Clinical Biochemistry (69 citations), Applied Microbiology and Biotechnology (16 citations) and Infectious Diseases (132 citations). Luke Anson has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Derrick W. Crook, Tim Peto, Louise Pankhurst, A. Sarah Walker, Anna E. Sheppard, Robert Sebra, Andrew Kasarskis, Nicole Stoesser, Amy J. Mathers and Adam Giess. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Health Technology Assessment, Journal of Clinical Microbiology, Journal of Medical Microbiology and Journal of Hospital Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.